3-hydroxybutyric acid has been researched along with Dyslipidemia in 3 studies
3-Hydroxybutyric Acid: BUTYRIC ACID substituted in the beta or 3 position. It is one of the ketone bodies produced in the liver.
3-hydroxybutyric acid : A straight-chain 3-hydroxy monocarboxylic acid comprising a butyric acid core with a single hydroxy substituent in the 3- position; a ketone body whose levels are raised during ketosis, used as an energy source by the brain during fasting in humans. Also used to synthesise biodegradable plastics.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Obesity is a global health problem caused by genetic, environmental, and psychological factors and is associated with various health disorders." | 1.91 | Prebiotic effect of poly-D-3-hydroxybutyrate prevents dyslipidemia in obese mice. ( Aihara, N; Kamiie, J; Mishima, M; Mizugaki, H; Nagane, M; Ogata, M; Okamatsu-Ogura, Y; Satoh, T; Shima, A; Suzuki, R; Suzuki, T; Takeda, S; Yamashita, T, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Mishima, M | 1 |
| Takeda, S | 1 |
| Nagane, M | 1 |
| Suzuki, T | 1 |
| Ogata, M | 1 |
| Shima, A | 1 |
| Aihara, N | 1 |
| Kamiie, J | 1 |
| Suzuki, R | 1 |
| Mizugaki, H | 1 |
| Okamatsu-Ogura, Y | 1 |
| Satoh, T | 1 |
| Yamashita, T | 1 |
| Pikija, S | 1 |
| Trkulja, V | 1 |
| Simundic, AM | 1 |
| Vrcek, E | 1 |
| Boskovic, K | 1 |
| Bacani, S | 1 |
| Li, D | 1 |
| Zhang, Y | 1 |
| Liu, Y | 1 |
| Sun, R | 1 |
| Xia, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Purified Anthocyanin on Oxidative Stress and Glycemic Control in Subjects With Type 2 Diabetes Mellitus: A Randomized, Double-Blinded, Placebo-Controlled Trial[NCT02317211] | Early Phase 1 | 70 participants (Actual) | Interventional | 2014-02-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for 3-hydroxybutyric acid and Dyslipidemia
| Article | Year |
|---|---|
Purified anthocyanin supplementation reduces dyslipidemia, enhances antioxidant capacity, and prevents insulin resistance in diabetic patients.
Topics: 3-Hydroxybutyric Acid; Aged; Anthocyanins; Antioxidants; Apolipoprotein B-48; Apolipoprotein C-III; | 2015 |
2 other studies available for 3-hydroxybutyric acid and Dyslipidemia
| Article | Year |
|---|---|
Prebiotic effect of poly-D-3-hydroxybutyrate prevents dyslipidemia in obese mice.
Topics: 3-Hydroxybutyric Acid; Animals; Bacteria; Diet, High-Fat; Dyslipidemias; Mice; Mice, Inbred C57BL; M | 2023 |
Is on-admission capillary blood beta-hydroxybutyrate concentration associated with the acute stroke severity and short-term functional outcome?
Topics: 3-Hydroxybutyric Acid; Adult; Aged; Aged, 80 and over; Brain Ischemia; Capillaries; Diabetes Complic | 2013 |